Fighting
Antibiotic
Failure
ON TWO
FRONTS
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-hm-diagnostic-new.png)
Diagnostic
Novel assay provides earlier and faster risk assessment of sepsis and enables targeted treatment.
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-hm-therapeutic.png)
Therapeutic
Patented pharmaceutical peptide targets currently untreatable biofilm infections. Innovative substrate-independent peptide coatings maintain sterile medical devices and implants.
The crisis: Widespread and deadly*
49 million/year
cases of sepsis
11 million
sepsis deaths a year
100%
incidence of sepsis in COVID deaths
10 to 1000x
more resistant to most antibiotics
0
drugs approved for biofilms
65%
of all infections are biofilms
* Data on file
Investment Highlights
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-invest-1.png)
Large Addressable Global Markets
With NO efficient clinical solutions (unmet medical needs)
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-invest-2.png)
Novel Technologies
In the early identification of sepsis and treatment of biofilm Infections
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-invest-3.png)
Extensive Intellectual Property
Portfolio of both Diagnostics and Therapeutics
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-invest-4.png)
Near-term Revenue Models
With multiple corporate partnership targets
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-invest-5.png)
Publicly-Listed
For enhanced shareholder liquidity
![](https://asepmedical.com/wp-content/uploads/2021/11/icon-invest-6.png)
Experienced Management Team
With proven track records in med-tech and biopharma
Multibillion-dollar opportunity
As sepsis and antibiotic-resistant infections continue to be a severe burden on the healthcare system, Asep Inc. offers excellent investment potential, with a combined market of $179 billion, and robust growth.
$41.9B Global Antibiotic Market CAGR: 3%
Global MRSA Market*
$1.0B
CAGR: 4.4%
Global Device Infection Market
$2.0B
CAGR: 3.6%
Global CRS Market
$2.1B
CAGR: 7.4%
Global Ear Infection Market
$2.8B
CAGR: 5%
Global Bacterial Vaginosis
$4.5B
CAGR: 9%
Global Urinary Tract Infections
$9.5B
CAGR: 3.6%
Global Wound Care Market
$20B
CAGR: 4.1%
$1.0B Global Sepsis Dx CAGR: 8.5%
WEBINARS
Click the link below to view our archived webinars.
Contact
![asep_logo_blue_text1](https://asepmedical.com/wp-content/uploads/2023/03/asep_logo_blue_text1.png)
ASEP and its subsidiaries' technologies have not received marketing authorization
and are not currently available for purchase. © 2023 All Rights Reserved